Computational guided approach for drug repurposing against SARS-CoV-2

Background: In the current SARS-CoV-2 outbreak, drug repositioning emerges as a promising approach to develop efficient therapeutics in comparison to de novo drug development. The present investigation screened 130 US FDA-approved drugs including hypertension, cardiovascular diseases, respiratory tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Jigisha, Ghildiyal, Tanmay, Madhwal, Aakanksha, Bhatt, Rishabh, Verma, Devvret, Rai, Nishant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923689/
http://dx.doi.org/10.2217/fvl-2020-0403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923689/
http://dx.doi.org/10.2217/fvl-2020-0403

Ejemplares similares